Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Heron Therapeutics, Inc. has good growth characteristics. Heron Therapeutics, Inc. is not very popular among insiders. Heron Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for pati...
HRTX Fundamental Data by TradingView

News

Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors
Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors

SeekingAlpha Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors...\n more…

Insider Returns Down To US$248k As Heron Therapeutics' Stock Dips 10%
Insider Returns Down To US$248k As Heron Therapeutics' Stock Dips 10%

Simply Wall St Insiders who purchased Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shares in the past 12 months are unlikely to be deeply...\n more…

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer

PR Newswire Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer PR Newswire SAN DIEGO, Sept...\n more…

Panagora Asset Management Inc. Acquires 186,802 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)
Panagora Asset Management Inc. Acquires 186,802 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)

Ticker Report Panagora Asset Management Inc. lifted its holdings in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 49.8% in the 2nd quarter, according to the company in its most recent...\n more…

California State Teachers Retirement System Has $29,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)
California State Teachers Retirement System Has $29,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)

Ticker Report California State Teachers Retirement System lessened its position in Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 38.9% during the first quarter, Holdings Channel reports. The...\n more…

Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC

Ticker Report Needham Company LLC reiterated their buy rating on shares of Heron Therapeutics (NASDAQ:HRTX - Free Report) in a research report released on Wednesday morning, Benzinga reports. They currently...\n more…